Introduction
Haematopoietic cells originate from different embryonic sites during development and are generated in close association with the vascular endothelium. Some of the best characterized haematopoietic sites in the embryo include the yolk sac (Yoder and Hiatt, 1997; Yoder et al, 1997a, b) , the intra-embryonic para-aortic splanchnopleura (P-sp)/AGM (aorta-gonad-mesonephros) (Medvinsky and Dzierzak, 1996; Cumano et al, 2001) , umbilical and vitelline arteries (de Bruijn et al, 2000) , allantois (Zeigler et al, 2006; Dieterlen-Lievre, 2007) and placenta (Gekas et al, 2005; Ottersbach and Dzierzak, 2005) . The AGM region generates the first adult repopulating haematopoietic stem cells (HSCs) but it is as yet unclear whether some or all these tissues can de novo generate such cells. It is thought that niche-dependent signals can influence the properties of the presumptive haematopoieitc cells as they emerge and function to meet the haematopoietic needs of the embryo. Thus, a variety of haematopoietic cells (as defined by functional assays) emerge, including myeloid progenitors, multipotent progenitors and in vivo repopulating HSC.
The Notch pathway is involved in the regulation of cell-fate decisions by cell-cell interactions in a variety of developmental systems, including haematopoiesis. In adult haematopoiesis, the best characterized function of Notch is in the development of T (Radtke et al, 1999) and B cells (Pui et al, 1999; Tanigaki et al, 2002 ) (reviewed in Radtke et al, 2004) . In addition, Notch is likely to participate in other aspects of haematopoietic homoeostasis including stem cell maintenance as shown by the ability to immortalize pluripotent haematopoietic cells (Varnum-Finney et al, 2000) . It has been shown that germline mutant embryos deficient for Notch1 and RBPjk cannot generate intra-embryonic HSC in different organisms, whereas no major haematopoietic defects have been found in the yolk sac haematopoiesis of these mutants (Kumano et al, 2003; Burns et al, 2005; Robert-Moreno et al, 2005 . Moreover, Notch1-deficient ES-cell derived chimaeras never contributed to adult haematopoiesis but did contribute to yolk sac-derived haematopoiesis (Hadland et al, 2004) . Several studies in zebrafish also support a role for Notch signalling in definitive but not primitive haematopoiesis (Burns et al, 2005; Gering and Patient, 2005) . Although these observations suggest that Notch is involved in the generation of the definitive HSC in the embryo, in vivo experiments in which Notch1 or Jagged1 was conditionally deleted in the adult by the interferon-inducible Mx-cre failed to support the idea that Notch has a similar function in adult HSCs (Radtke et al, 1999; Mancini et al, 2005) . In addition, a conclusive proof for the haematopoietic Notch function in the embryo remains elusive, mainly because of the abnormal arterial development of all the analysed Notch mutants.
The onset of the haematopoietic programme in the aortic endothelial-like cells is characterized by the transcriptional activation of the Runx1 and GATA2 genes, which are required for the formation of definitive HSC (Tsai et al, 1994; Okuda et al, 1996; North et al, 2002; Ling et al, 2004) . We previously described that GATA2 was a direct target of Notch in the AGM region (Robert-Moreno et al, 2005), and data on haematopoietic specification in zebrafish support Runx1 as a downstream factor of the genetic cascade initiated by Notch signalling (Burns et al, 2005) . However, there is no evidence that Runx1 is a direct target of Notch.
To further identify and characterize the genetic cascade involving Notch and its role in haematopoietic specification, we examined the putative haematopoietic defects on embryos deficient for Jagged1, Jagged2 or Delta4, the three ligands that are present in the dorsal aorta of the mid-gestation embryo. Notch ligands Jagged1, Jagged2 and Delta4 are known to interact and activate all Notch receptors (Shimizu et al, 2000; Shutter et al, 2000) . Targeted disruption of each of these genes results in embryonic (Jagged1 and Delta4) or perinatal (Jagged2) lethality, suggesting that all have essential, non-redundant functions (Jiang et al, 1998; Xue et al, 1999; Duarte et al, 2004; Krebs et al, 2004) . In vitro cultures with Jagged1 (Varnum-Finney et al, 1998; Karanu et al, 2000) , Delta1 (Varnum-Finney et al, 2003) and Delta4 (Dando et al, 2005) have been used for expansion of haematopoietic progenitors or stem cells with the purpose of improving cell therapy protocols. However, to date there is no proof for the involvement of Notch ligands in the embryonic haematopoiesis and maintenance of adult haematopoietic progenitors as well as the individual contribution of these ligands in vivo.
Here, we describe that the Notch ligand Jagged1 is directly involved in activating Notch in AGM haematopoietic cells, non-cell autonomously. This results in the transcriptional activation of GATA2 in these cells and the formation of the HSC and their progeny.
Results

Heterogeneous expression of Notch family members within the aortic haematopoietic clusters
Previously, we showed that Notch1, Notch4, Jagged1, Jagged2 and Delta4 are expressed in the mid-gestation AGM region in the mouse embryo (Robert-Moreno et al, 2005) . We further studied the expression pattern of these molecules in the haematopoietic clusters emerging from the aortic endothelium at E9. 5-10.5 (20-40sp) . We found that Notch1 is expressed in most of the cells of the haematopoietic clusters similar to Jagged1 expression. In contrast, Notch4 is strongly decreased in the clustered cells compared with the surrounding endothelium ( Figure 1A ). Profound heterogeneity was found in the expression patterns of Jagged2 and Delta4 ligands in these structures. Jagged2 was heterogeneously expressed within the cells of a single cluster, whereas Delta4 was expressed in individual clusters and completely absent in others. Detection of activated Notch1 ( Figure 1B ) with specific antibody recognizing cleaved-Notch1 (Souilhol et al, 2006; Del Monte et al, 2007) , concomitant with the presence of the Notch target genes hes1, hrt1 and GATA2 mRNA ( Figure 1C topoietic defects observed in the Notch1 and RBPjk-null embryos (Kumano et al, 2003; Robert-Moreno et al, 2005) support the notion that Notch signalling has a pivotal function in the embryonic haematopoietic development.
Altered haematopoiesis in the AGM of Jagged1 but not Jagged2 mutant embryos To examine the contribution of the different Notch ligands on embryonic haematopoiesis in vivo, we took advantage of the Ly-6A-GFP (Sca-1-GFP) transgenic mice . These mice express GFP in the first HSCs, in cells of the haematopoietic clusters and haemogenic endothelium of the E10 aorta and have been used to quantitate haematopoietic clusters in normal and GATA2 mutant embryos (Ling et al, 2004) . We crossed Jag1 þ /D or Jag2 þ /D (Jiang et al, 1998; Xue et al, 1999) /Ly-6A-GFP embryos was reduced at least 50% at three different developmental stages (Figure 2A and B) , suggesting an important role for Jagged1 in embryonic haematopoiesis. Although the Notch ligand Delta4 was also expressed in the aorta, the strong vascular defects of the Delta4 þ /À mutants precluded this study (Duarte et al, 2004; Krebs et al, 2004) .
To further examine the influence of Notch ligands on haematopoietic development, haematopoietic progenitors in the different mutants were quantitated by colony-forming cell (CFC) assays. AGM tissues from E10-11 Jag1 contained a severely reduced number of total haematopoietic progenitors ( Figure 2C ) and all progenitor types (myeloid, erythroid and mix colonies) were reduced (data not shown) compared with both Jag1 þ / þ and Jag1
. In contrast, we did not detect any variation in the number and type of CFC in Jagged2 mutant AGMs. These results are in agreement with the absence of Ly-6A-GFP þ cells in the aorta of Jagged1 but not Jagged2 mutant embryos. The capacity of Jag1 D/D AGM tissues to generate haematopoietic cells was tested in liquid cultures. In the absence of stromal cells, a strong reduction in the percentage of CD45 þ cells generated from Jag1 D/D AGMs was observed as compared with the wild-type or heterozygous mutants (from 80% in Jag1
) as determined by flow cytometry ( Figure 2D ). However, we identified a profound heterogeneity between different littermate null embryos with a range from 0 to 35% of CD45 þ cells generated after liquid culture. This indicates variation in the penetrance of the Jagged1 deficiency (0-10% high penetrance and 10-35% low penetrance). We next co-cultured these cells with the OP9 stromal cell line that endogenously express Jagged1 ( Figure 2G ), to test whether the haematopoietic defect observed in the Jagged1 embryos was cell autonomous. When Jag1 D/D AGM cells were co-cultured with OP9 stroma, the percentage of CD45 þ cells generated increased up to fourfold (in both high and low penetrance null embryos) as compared with cells cultured without OP9, whereas we did not find any change in Jag1 þ / þ and Jag1 þ /D AGM cell cocultures ( Figure 2E ). Recovery of the CD45 þ population is concomitant with an increase in GATA2 expression in these cells (Supplementary Figure 1) . Overexpression of Jagged1 in OP9 cells did not further increase the recovery of CD45 þ cells obtained from Jag1 D/D AGMs (data not shown). To further confirm that Jagged1 was responsible for the haematopoietic recovery observed in the co-culture experiments, we isolated Jag1 þ / þ or Jag1 D/D murine embryonic fibroblast (MEF) (from E10.5 embryos) and used these cells as stromal layer. We observed a partial recovery in the number of CD45 þ haematopoietic cells when Jag1 Figure 2F ). Taken together, these results indicate that Jagged1 expression in the aorta is required in a non-haematopoietic cell autonomous manner for haematopoietic cell development. Interestingly, we found comparable levels of Jagged2 and Delta4 in both MEFs ( Figure 2G ) and AGM from Jag1 D/D ( Figure 2H ) embryos indicating that Jagged1 deficiency cannot be rescued by other Notch ligands.
Arterial fate is not affected in the Jagged1 mutant embryos Notch function is required for aorta specification in different organisms (Lawson et al, 2001; Duarte et al, 2004; Krebs et al, 2004) . As arterial determination precedes the haematopoietic cluster emergence in the mouse AGM, we tested whether the haematopoietic defects in the Jagged1 mutant embryos were due to a failure in the arterial programme. The expression of ephrinB2, which distinguishes arteries from veins before any structural, physiologic or functional distinctions (Wang et al, 1998; Adams et al, 1999) was examined by immunostaining of E10.5 AGM sections. We found that ephrinB2 is expressed in the arteries, including the aorta, of the Jag1 D/D embryos similar to the wild type and it is absent from the venous network ( Figure 3A ). To further confirm that arterial determination is not affected in these mutants, we tested the expression pattern of other arterial markers such as CD44 and a-smooth muscle actin (SMA). We found comparable expression of CD44 and SMA in Jag1 þ / þ and Jag1 Figure 3A ). Taken together, these results indicate that Jagged1-mediated activation of Notch is not required for arterial specification. Previous studies of aortas from Notch1 and RBPjk mutant embryos showed an increase in the number of endothelial cells concomitant with a reduction in haematopoietic cells, suggesting a switch in the balance between endothelial and haematopoietic cell fates from a common precursor. To analyse whether the endothelial lineage was favoured in the Jagged1 mutants, AGM sections from wild-type and mutant embryos were examined for the expression of endothelial markers CD31 and VE-cadherin. Increased expression levels of both endothelial markers were observed in the Jag1 D/D embryos compared with wild-type littermates ( Figure 3B) . Moreover, the aortic endothelial monolayer expressing CD31 and VE-cadherin lining the dorsal aorta displays, in these mutants, an abnormal architecture that resembles a multistratified endothelium. This phenotype is reminiscent of the one observed in the RBPjk mutant embryos (Robert-Moreno et al, 2005) .
Altogether these results indicate that the haematopoietic phenotype of the Jagged1 mutant embryos is not due to defective arterial specification, but instead suggest a defect in haematopoietic determination from the haemogenic endothelium of the AGM region.
GATA2 expression is compromised in Jagged1 mutants
Although we have previously shown that GATA2 is a direct target of Notch1 signalling, we next examined whether the lack of Jagged1 or Jagged2 influences GATA2 expression in the aortic endothelium and haematopoietic clusters. The expression of Runx1, another pivotal haematopoietic transcription factor in the emergence of the aortic haematopoietic clusters, was also examined by in situ hybridization. E10.5-11 Jag1 D/D showed a complete lack of GATA2 expression in the aorta ( Figure 4A ). Interestingly, only a few cells expressing Runx1 were found in three out of six mutant embryos. Expression of Runx1 and GATA2 was also absent from E9.5 Delta4À/À embryos (data not shown). In contrast, both transcription factors were expressed in E10.5-11 Jag2
embryos and their expression patterns were similar to those found in wild-type littermates (Figure 4) . However, some reduction in the total number of GATA2-expressing cells was found in the AGM region of these embryos (Table I) . As a direct target for Notch1 in the AGM, we hypothesized that recruitment of Notch1 to the GATA2 promoter may be affected and this may influence GATA2 expression in the Jagged1 mutant embryos. By chromatin IP assay followed by qPCR analysis, we detected Notch1 recruitment on Jag1 þ /D E10.5 AGM cells, whereas no Notch1 recruitment was detected in the GATA2 promoter of Jag1 D/D AGM at the same developmental stage (35-40 sp) ( Figure 4C ).
Ectopic GATA2 expression rescues Jagged1 mutant haematopoiesis
As shown in Figure 2 , haematopoietic cells cannot be properly generated from Jag1 D/D AGM in liquid cultures unless exogenous Jagged1 signalling is provided. As GATA2 expression is downstream of Notch activation in the AGM and it is absent in the haematopoietic clusters from Jagged1-null embryos, we next tested whether enforced expression of GATA2 on E10.5 AGM cells was sufficient to rescue Jag1
haematopoietic defects in vitro. To further demonstrate that GATA2 is able to rescue the haematopoietic Notch signalling defect avoiding the putative previous defects in Jag1 D/D during AGM development, we used the g-secretase inhibitor DAPT to block Notch activation in the AGM cultures and transduced with pHRGFP or pHRhGATA2 lentivirus. After 7 days, we found a decrease in the percentage of CD45 þ cells in the control-transduced cells treated with DAPT compared to DMSO-treated cultures (P ¼ 0.05). Interestingly, this effect was abrogated by GATA2 expression ( Figure 5C ). Moreover, a strong inhibitory effect of DAPT (100-fold) was observed on the number of progenitors (CFC) that was significantly recovered in GATA2-transduced cells (P ¼ 0.002) ( Figure 5D ). Consistent with the higher effect of Notch inhibition on CFC assay, we found that DAPT preferentially affects the number of ckit þ CD45 þ progenitors compared with total CD45 þ cells in AGM cultures (data not shown).
Altogether our results indicate that Jagged1-mediated activation of Notch is required for the proper expression of GATA2 in the haematopoietic cells of the embryonic aorta, and that GATA2 is a required haematopoietic effector of Notch signalling in these cells.
Discussion
Our present work demonstrates that the Notch ligand Jagged1 is responsible for the Notch activation that permits the proper execution of the haematopoietic programme in the dorsal aorta of the AGM region. This occurs, at least partially, through GATA2, a direct transcriptional target of Notch1.
We have previously shown that Delta4, Jagged1 and Jagged2 are expressed in the mid-gestation aortic endothelium; therefore, they were all candidates to activate Notch in the AGM (Robert-Moreno et al, 2005) . We have now focused on studying the loss-of-function mutant embryos for Jagged1 (Xue et al, 1999) , Jagged2 (Jiang et al, 1998) and Delta4 (Duarte et al, 2004; Krebs et al, 2004) to identify the putative haematopoietic Notch ligand. We found that Jagged1, but not Jagged2, is responsible for Notch activation in haematopoietic cells in the dorsal aorta. Different Notch ligands, including Jagged1, had been previously shown to influence HSCs in vitro and Jagged1 may be an important component of the osteoblastic niche for maintaining adult HSC in the bone marrow (Calvi et al, 2003) . Our results demonstrate for the first time that the Notch ligand Jagged1 is required for the embryonic haematopoietic development in vivo.
Although preliminary studies with the Delta4 heterozygous embryos also showed lack of haematopoiesis, these mutants display severe vasculogenic defects together with the loss of the arterial cell fate, which strongly compromised the study of haematopoiesis in these mutants. Further studies of the Delta4 deficiency in AGM, by using cell-specific crerecombinase expression in the appropriate cells, without disturbing the arterial identity should determine the importance of Delta4 in embryonic haematopoiesis.
The role of Notch in actively promoting arterial identity is well documented in several systems (Lawson et al, 2001; Duarte et al, 2004; Krebs et al, 2004) . Conversely, COUP-TFII is required in veins to repress Notch signalling and maintain vein identity (You et al, 2005) . The link between arterial determination and haematopoiesis development is supported by the abnormal generation of haematopoeitic progenitors in the veins of mutant embryos showing vein-to-artery conversion, such is the case for activin receptor such as kinase1 (ACVRL1) (Urness et al, 2000) or COUP-TFII (You et al, 2005) -deficient embryos. However, it is not well established whether haematopoiesis can occur in the absence of arterial specification, although in zebrafish, haematopoietic cells can originate from vessels that do not express EphrinB2 after N1IC induction (Burns et al, 2005) . We now demonstrate that Jagged1-null embryos fail to generate haematopoietic cells but display normal expression of arterial markers such as ephrinB2 or CD44. This observation is extremely relevant as it is the first time that Notch signalling is directly associated with the generation of haematopoietic cells independently of its role in arterial development. This is in contrast with the previously analysed Notch mutants in which arterial deter- mination, most likely a requirement for haematopoiesis to progress, was also affected (Duarte et al, 2004; Krebs et al, 2004; Gridley, 2007) . We previously described that Notch1/RBPjk signalling participates in the transcriptional regulation of the haematopoietic transcription factor GATA2 (Robert-Moreno et al, 2005) . We have now found that recruitment of Notch1 to the GATA2 promoter depends on Jagged1. It has been proposed that loss of Runx1 is responsible for the haematopoietic defects in mouse Notch1 (Nakagawa et al, 2006) and zebrafish mind bomb mutants (Burns et al, 2005) . However, we have found that Runx1 is expressed at low levels in the aorta of 50% of Jagged1 null mutants, which absolutely fail to express GATA2. The fact that GATA2 is involved in regulating Runx1 expression (Nottingham et al, 2007) may explain the reduced levels of this transcription factor found in the Jagged1 null mutants. Indeed, we have been able to detect increased expression of Runx1 in the CD45 þ population in one out of two Jag1 D/D AGM cultures transduced with GATA2 lentivirus (Supplementary Figure 2) . Gene targeting studies revealed the importance of GATA2 for haematopoiesis as GATA2 À/À embryos have reduced numbers of haematopoietic cells (Tsai et al, 1994) ; there is no contribution of GATA2 À/À ES-derived cells to any haematopoietic tissue (Tsai et al, 1994) and GATA2 haploinsufficiency results in different HSC abnormalities (Ling et al, 2004; Rodrigues et al, 2005) . Our experiments demonstrate that re-expression of GATA2 partially reverts the haematopoietic defects of Jagged1 null embryos, suggesting that GATA2 is not the only Notch target required for embryonic haematopoiesis.
There is genetic evidence showing that haematopoietic and endothelial cells share a common genetic programme and come from a common progenitor (the haemangioblast). For example, the targeted disruption of the vascular endothelial growth factor and the tyrosine kinase Flk1 (Shalaby et al, 1995) results in complete deficiencies of both vascular and haematopoietic systems (Ferrara et al, 1996; Carmeliet et al, 1999) . Moreover, in vivo labelling studies in the chick showed the endothelial origin of the haematopoietic clusters emerging in the aorta (Jaffredo et al, 1998) . There are many evidences that support the existence of a common progenitor in the yolk sac and the AGM region, as an early progenitor for both lineages (Eichmann et al, 1997; Choi et al, 1998; Sabin, 2002; Huber et al, 2004) . We have consistently found that different Notch pathway mutants contain an excess of endothelial cells that is concomitant with the absence of haematopoietic clusters in the aorta (Kumano et al, 2001; Robert-Moreno et al, 2005) . This observation strongly suggests that haematopoietic progenitors assume the endothelial fate in the absence of Notch signalling.
Taken together, our results indicate that Jagged1-mediated activation of Notch1 is responsible for regulating GATA2 expression in the AGM, which in turn is essential for maintaining intraembryonic haematopoiesis in the mouse.
Materials and methods
Animals
Ly-6A/sca-GFP mice and Jagged1 D/D -and Jagged2 þ /D -null mutant mice have been extensively characterized (Jiang et al, 1998; Xue et al, 1999; de Bruijn et al, 2002) . Mice and embryos were genotyped by PCR, or under the UV microscope for GFP expression. Jag1 D/ þ and Jag2 D/ þ were crossed with Ly6A/sca-GFP and bred into C57BL6/J. CD1 and C57BL6/J embryos were used indistinctly for whole mount in situ hybridization (WISH). Animals were kept under pathogen-free conditions and all procedures were approved by the Animal Care Committee. Embryos were obtained from timed pregnant females and somite pairs were counted for precise timing.
Haematopoietic colony assay
Dissected AGM was dissociated in 0.12% collagenase (Sigma) in PBS supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (Biological Industries) for 1 h at 371C and cells were plated in M-5323 semisolid medium (Stem Cell Technologies). After 7 days the presence of haematopoietic colonies was scored under the microscope.
Haematopoietic liquid cultures
The AGM region from E10.5 embryos was dissociated in 0.12% collagenase (Sigma) in PBS supplemented with 10% FBS and penicillin/streptomycin (Biological Industries) for 1 h at 371C. Cells were incubated in Iscove's, 10% FBS, 10% IL3-and 10% SCFconditioned medium plus 0.2 mg/ml IL6, 0.1 mg/ml flt3. Cells were harvested after 7-10 days for FACS analysis or CFC assay.
For OP9 cultures, OP9 cells were maintained in MEMa, 10% FBS and plated in 24-well plates 2 days before the AGM liquid cultures.
For MEF stromal cultures, embryos of different genotypes were mechanically dissociated with a scalpel and pipetting and plated on DMEM, 10% FBS until confluence. Twenty-four-well plates with MEF stromal cells were used for AGM liquid cultures.
RT-PCR
Total RNA was extracted with Qiagen kit, and RT-First Strand cDNA Synthesis kit (Amersham Pharmacia Biotech, GE Healthcare, Buckinghamshire, UK) was used. qRT-PCR was performed in LightCycler480 system using SYBR Green I Master kit (Roche, Basel, Switzerland).
Lentiviral constructs and infection
Flag-tagged GATA2 was subcloned into the pHR-SIN-CSGW-EGFP lentiviral expression construct under control of the SFFV promoter (Demaison et al, 2002) . Vector components were a kind gift from Adrian Thrasher. Recombinant lentiviruses were produced by transient transfection of 293T cells according to Tronolab protocols (http://tronolab.epfl.ch/page58122.html). Briefly, subconfluent 293T cells were co-transfected with 20 mg of transfer vector (pHRGFP or pHRhGATA2), 15 mg of packaging plasmid (psPAX2) and 6 mg of envelope plasmid (pMD2.G) by calcium phosphate precipitation. After 3 days, supernatant was ultracentrifuged in Beckman L-70 at 26 000 r.p.m. for 2 h at 41C in SW41 rotor, and viral pellet resuspended in 100 ml of PBS. Fresh viral suspension (20 ml) was used per infection. 
Flow cytometry analysis
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) analysis was performed as described previously (Aguilera et al, 2004) . In brief, crosslinked chromatin from E10.5 dissected AGMs was sonicated with a UP50H Ultrasonic Processor, and precipitated with anti-N1 antibody (sc-6014). After crosslinkage reversal, DNA was used as a template for PCR to detect the mouse GATA2 promoter (5 0 GCACGGTGTGAG AACCTGATTTC3 0 and 5 0 TCCCAAAGTCTGTGTCTTG AGAGC3 0 . qPCR was performed with SYBR Green I Master (Roche) in LightCycler480 system. Immunostaining E10.5 embryos were fixed overnight in 4% paraformaldehyde (Sigma) at 41C and frozen in Tissue-tek (Sakura). Sections (10 mm) were fixed with À201C methanol for 15 min and block-permeabilized in 10% FBS, 0.3% Surfact-AmpsX100 (Pierce) and 5% non-fat milk in PBS for 90 min at 41C. Samples were stained with a-CD31 (PECAM1; Pharmingen at 1:50) or a-CD44 (Pharmingen, 1:50) in 10% FBS, 5% non-fat milk in PBS overnight and HRP-conjugated secondary antibody (Dako) at 1:100 for 90 min and developed with Cy3-or FITC-coupled tyramide (PerkinElmer). a-SMA (Lab Vision) was used at 1:100 and Alexa Fluor 488-conjugated donkey-antirabbit (Invitrogen, 1:500) as a secondary antibody. For a-N1Icv (Cell Signaling at 1:100) or a-EphrinB2 (R&D systems at 1:200) or aJagged1 (sc-6011, 1:400) immunofluorescence was performed in paraffin-embedded sections, antigen retrieval was performed in 10 mM Na citrate pH ¼ 6, 20 min in autoclave. Primary antibody was incubated in 3% BSA, 20 mM MgCl 2 , 0.3% Tween20, 5% FBS in PBS overnight and HRP-conjugated secondary antibody (Dako) at 1:200 for 90 min and developed using the tyramide amplification system, TSA-Plus Cyanine3/Fluorescein System (PerkinElmer). Sections were mounted in Vectashield medium with 4 0 6-diamidino-2-phenylindole (DAPI) (Vector).
WISH
WISH was performed according to standard protocols (de la Pompa et al, 1997). For histological analysis, precisely timed embryos were fixed overnight at 41C in 4% paraformaldehyde, dehydrated and embedded in Paraplast (Sigma). Embryos were sectioned in a Leica-RM2135 at 7 mm and mounted with DPX (Roche).
Image acquisition
Images were acquired with an Olympus BX-60 using a Spot camera and Spot3.2.4 software (Diagnostic Instruments) or a Leica TCS-NT laser scanning confocal microscope equipped with the Â 63 Leitz Plan-Apo objective (NA 1.4). Representative images were edited on Adobe Photoshop 6.0 software.
